Passage Bio, Inc.
PASG
$0.3117
-$0.0145-4.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -64.77M | -68.80M | -76.57M | -84.44M | -102.06M |
| Total Depreciation and Amortization | 3.08M | 3.17M | 3.37M | 3.55M | 3.72M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.75M | 9.37M | 11.49M | 13.20M | 14.74M |
| Change in Net Operating Assets | -4.02M | -2.76M | -9.03M | -7.06M | 5.34M |
| Cash from Operations | -47.96M | -59.03M | -70.74M | -74.75M | -78.26M |
| Capital Expenditure | -34.00K | -33.00K | -17.00K | -120.00K | -146.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 54.98M | 48.90M | 56.37M | 69.39M | 65.38M |
| Cash from Investing | 54.95M | 48.87M | 56.35M | 69.27M | 65.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.87M | 8.87M | 8.87M | 8.88M | 135.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8.87M | 8.87M | 8.87M | 8.88M | 135.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.86M | -1.29M | -5.52M | 3.40M | -12.89M |